While COVID鈥檚 often deadly outcome has resulted in the worst pandemic in a century, studies are unveiling a post-COVID phase for survivors during which neuropsychiatric symptoms, such as fatigue, anxiety and depression, can occur. How to treat this debilitating phase, called NeuroCOVID, is the challenge City College of New York biomedical engineer Marom Bikson and his team are tackling. The first stage of COVID is characterized by fever, heart or lung problems. NeuroCOVID is second stage, characterized by one or a combination of symptoms like vertigo, loss of smell, headaches, fatigue and
Read more